96 related articles for article (PubMed ID: 224694)
1. Somatomedin and growth hormone studies in pediatric renal allograft recipients who receive daily prednisone.
Pennisi AJ; Costin G; Phillips LS; Malekzadeh MM; Uittenbogaart C; Ettenger RB; Fine RN
Am J Dis Child; 1979 Sep; 133(9):950-4. PubMed ID: 224694
[TBL] [Abstract][Full Text] [Related]
2. Prednisone inhibits the efficacy of recombinant human growth hormone in pediatric renal transplant recipients.
Ingulli E; Singh A; Moazami S; Tejani A
Kidney Int Suppl; 1993 Oct; 43():S65-70. PubMed ID: 8246373
[TBL] [Abstract][Full Text] [Related]
3. Linear growth and somatomedin activity in renal allograft recipients.
Pennisi AJ; Phillips LS; Uittenbogaart C; Ettenger RB; Malekzadeh MH; Fine RN
Proc Clin Dial Transplant Forum; 1976 Nov 19-22; 6():168-71. PubMed ID: 197583
[No Abstract] [Full Text] [Related]
4. Combined test of hypothalamic-pituitary function in growth retarded children treated with growth hormone. I. Secretion of growth hormone and somatomedin before and after treatment.
Kastrup KW; Andersen H; Eskildsen PC; Jacobsen BB; Krabbe S; Petersen KE
Acta Paediatr Scand Suppl; 1979; 277():8-13. PubMed ID: 396757
[TBL] [Abstract][Full Text] [Related]
5. Somatomedin and growth after renal transplantation.
Saenger P; Wiedemann E; Schwartz E; Korth-Schutz S; Lewy JE; Riggio RR; Rubin AL; Stenzel KH; New MI
Pediatr Res; 1974 Mar; 8(3):163-9. PubMed ID: 4361148
[No Abstract] [Full Text] [Related]
6. Somatomedin levels in the diagnosis and therapy of growth hormone deficiency.
Giannella-Neto D; Wajchenberg BL; Mendonca BB; Liberman B; Nery M; Macchione M; Spencer EM
Horm Metab Res; 1988 Mar; 20(3):175-81. PubMed ID: 3384400
[TBL] [Abstract][Full Text] [Related]
7. A placebo-controlled, double-blind trial of growth hormone treatment in prepubertal children after renal transplant.
Hokken-Koelega AC; Stijnen T; de Jong RC; Donckerwolcke RA; Groothoff JW; Wolff ED; Blum WF; de Muinck Keizer-Schrama SM; Drop SL
Kidney Int Suppl; 1996 Jan; 53():S128-34. PubMed ID: 8771007
[TBL] [Abstract][Full Text] [Related]
8. Therapy with a new glucocorticoid: effect of deflazacort on linear growth and growth hormone secretion in renal transplantation.
Ferraris JR; Pasqualini T
J Rheumatol Suppl; 1993 Apr; 37():43-6. PubMed ID: 8501752
[TBL] [Abstract][Full Text] [Related]
9. Growth hormone and the skeleton in pediatric renal allograft recipients.
Sanchez CP; Kuizon BD; Goodman WG; Gales B; Ettenger RB; Boechat MI; Wang Y; Elashoff R; Salusky IB
Pediatr Nephrol; 2002 May; 17(5):322-8. PubMed ID: 12042887
[TBL] [Abstract][Full Text] [Related]
10. Somatomedin activity and growth hormone concentration in pediatric renal allograft recipients.
Pennisi AJ; Ettenger RB; Costin G; Phillips L; Malekzadeh MH; Uittenbogaart CH; Fine RN
Trans Am Soc Artif Intern Organs; 1979; 25():455-8. PubMed ID: 392881
[No Abstract] [Full Text] [Related]
11. Effects of alternate-day or daily prednisone treatment on GH and cortisol levels in growth-retarded children after renal transplantation.
Hokken-Koelega AC; de Muinck Keizer-Schrama SM; Drop SL
J Pediatr Endocrinol; 1994; 7(2):119-25. PubMed ID: 7520318
[TBL] [Abstract][Full Text] [Related]
12. Plasma somatomedin activity and urinary hydroxyproline excretion during administration of human growth hormone in children with short stature. Short-term effects.
Wit JM; Van den Brande JL
Horm Res; 1984; 19(4):205-15. PubMed ID: 6745841
[TBL] [Abstract][Full Text] [Related]
13. Effects of growth hormone administration in pediatric renal allograft recipients.
Bartosh S; Kaiser B; Rezvani I; Polinsky M; Schulman S; Palmer J; Baluarte HJ
Pediatr Nephrol; 1992 Jan; 6(1):68-73. PubMed ID: 1536744
[TBL] [Abstract][Full Text] [Related]
14. Growth hormone--dependent growth failure.
Frazer T; Gavin JR; Daughaday WH; Hillman RE; Weldon VV
J Pediatr; 1982 Jul; 101(1):12-5. PubMed ID: 7086612
[TBL] [Abstract][Full Text] [Related]
15. Serum somatomedin A in growth retarded children.
Hizuka N; Takano K; Shizume K; Kawai K
Acta Endocrinol (Copenh); 1978 Aug; 88(4):625-32. PubMed ID: 210608
[TBL] [Abstract][Full Text] [Related]
16. Growth failure, somatomedin and growth hormone levels in juvenile diabetes mellitus--a pilot study.
Nash H
Aust N Z J Med; 1979 Jun; 9(3):245-9. PubMed ID: 223535
[TBL] [Abstract][Full Text] [Related]
17. Growth hormone and somatomedin in insulin-dependent diabetes mellitus.
Horner JM; Kemp SF; Hintz RL
J Clin Endocrinol Metab; 1981 Dec; 53(6):1148-53. PubMed ID: 7298798
[TBL] [Abstract][Full Text] [Related]
18. Relations between immunoreactive somatomedin C, insulin and T3 patterns during fasting in obese subjects.
Caufriez A; Golstein J; Lebrun P; Herchuelz A; Furlanetto R; Copinschi G
Clin Endocrinol (Oxf); 1984 Jan; 20(1):65-70. PubMed ID: 6362925
[TBL] [Abstract][Full Text] [Related]
19. Plasma somatomedin-C as a screening test for growth hormone deficiency in children and adolescents.
Moore DC; Ruvalcaba RH; Smith EK; Kelley VC
Horm Res; 1982; 16(1):49-55. PubMed ID: 7200069
[TBL] [Abstract][Full Text] [Related]
20. Growth hormone (GH) and somatomedin c (SM-C) in Venezuelan boys.
Castro A; Castro S
J Trop Pediatr; 1988 Aug; 34(4):201-2. PubMed ID: 3172333
[No Abstract] [Full Text] [Related]
[Next] [New Search]
